Jon Smith looks back on some words of wisdom from Warren Buffett about how and where to invest as the market keeps rallying.

This means that over the past quarter there has been an increase of insiders buying their shares of GSK in relation to earlier this year. TipRanks tracks over 100,000 company insiders, identifying the ...

The multi-programme partnership will also see Relation applying its platform to a range of fibrotic conditions as well as ...

TD Cowen analyst Steve Scala maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of $45.00. The ...